ANATOMY OF A FAILURE TO LAUNCH: BARRIERS TO GENERIC MARKET ENTRY AND THE USE OF COMPETITION LAW AS A REMEDY
Section
Health & Consumers
Event Description
The webinar will be the occasion for the launch of a White Paper entitled “Anatomy of a failure to launch: A review of barriers to generic and biosimilar entry and the use of competition law”.
The discussion will focus on how to make sure that current barriers to generic and biosimilar medicines market entry can be tackled in order to avoid any unnecessary delays to patient access.
The launch of the White Paper aims to inform the current debate around the IP strategy in the context of the broader Pharmaceutical Strategy of the European Commission. Discussions will include how to deal with IP and patent quality, patent linkage, pricing strategies, as well as ways to ensure effective competition in the pharmaceutical market.
Events of the week
Jobs
Euractiv
Euractiv
Euractiv
Plastics Europe
Plastics Europe
Plastics Europe
FIA Region I
European Space Policy Institute
Vantage Specialty Chemicals
European Institute of Peace
EURACTIV News
- EU to world: Don’t depend solely on China to hit renewable goals
- South Africa challenges EU at WTO over restrictions on citrus fruit trade
- France unveils 55 ‘turnkey’ sites for clean industry
- Georgia ruling party presses on with ‘foreign agents’ bill opposed by EU
- US expected to veto Palestinian request for full UN membership